Literature DB >> 15372110

A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.

Kenji Sugimoto1, Mutsuhiro Ohata, Jun Miyoshi, Hiroyoshi Ishizaki, Naotake Tsuboi, Akio Masuda, Yasunobu Yoshikai, Masaya Takamoto, Kazuo Sugane, Seiichi Matsuo, Yasuhiro Shimada, Tetsuya Matsuguchi.   

Abstract

A serine/threonine protein kinase, Cot/Tpl2, is indispensable for extracellular signal-regulated kinase (ERK) activation and production of TNF-alpha and PGE2 in LPS-stimulated macrophages. We show here that Cot/Tpl2 is also activated by other Toll-like receptor (TLR) ligands. Bacterial DNA rich in the dinucleotide CG (CpG-DNA), unlike LPS or synthetic lipopeptide, activated ERK in a Cot/Tpl2-independent manner. Peritoneal macrophages and bone marrow-derived DCs from Cot/Tpl2-/- mice produced significantly more IL-12 in response to CpG-DNA than those from WT mice. Enhanced IL-12 production in Cot/Tpl2-/- macrophages is, at least partly, regulated at the transcriptional level, and the elevated IL-12 mRNA level in Cot/Tpl2-/- macrophages is accompanied by decreased amounts of IL-12 repressors, such as c-musculoaponeurotic fibrosarcoma (c-Maf) and GATA sequence in the IL-12 promoter-binding protein (GA-12-binding protein; GAP-12) in the nucleus. Consistently, Cot/Tpl2-/- mice showed Th1-skewed antigen-specific immune responses upon OVA immunization and Leishmania major infection in vivo. These results indicate that Cot/Tpl2 is an important negative regulator of Th1-type adaptive immunity, that it achieves this regulation by inhibiting IL-12 production from accessory cells, and that it might be a potential target molecule in CpG-DNA-guided vaccination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372110      PMCID: PMC516257          DOI: 10.1172/JCI20014

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis.

Authors:  K M Erny; J Peli; J F Lambert; V Muller; H Diggelmann
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

2.  Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.

Authors:  C Tsatsanis; C Patriotis; P N Tsichlis
Journal:  Oncogene       Date:  1998-11-19       Impact factor: 9.867

Review 3.  Antibody class switching.

Authors:  J Stavnezer
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

4.  The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.

Authors:  B de Saint-Vis; I Fugier-Vivier; C Massacrier; C Gaillard; B Vanbervliet; S Aït-Yahia; J Banchereau; Y J Liu; S Lebecque; C Caux
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

5.  The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.

Authors:  L DiMolfetto; H A Neal; A Wu; C Reilly; D Lo
Journal:  Cell Immunol       Date:  1998-01-10       Impact factor: 4.868

6.  K-ras is essential for the development of the mouse embryo.

Authors:  K Koera; K Nakamura; K Nakao; J Miyoshi; K Toyoshima; T Hatta; H Otani; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

7.  CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation.

Authors:  H Häcker; H Mischak; T Miethke; S Liptay; R Schmid; T Sparwasser; K Heeg; G B Lipford; H Wagner
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

8.  Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development.

Authors:  S Stoll; H Jonuleit; E Schmitt; G Müller; H Yamauchi; M Kurimoto; J Knop; A H Enk
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

9.  TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.

Authors:  M P Belich; A Salmerón; L H Johnston; S C Ley
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells.

Authors:  W C Brown; D M Estes; S E Chantler; K A Kegerreis; C E Suarez
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  34 in total

1.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

2.  Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.

Authors:  Jeffrey Lee Jensen; Alexander Rakhmilevich; Erika Heninger; Aimee Teo Broman; Chelsea Hope; Funita Phan; Shigeki Miyamoto; Ioanna Maroulakou; Natalie Callander; Peiman Hematti; Marta Chesi; P Leif Bergsagel; Paul Sondel; Fotis Asimakopoulos
Journal:  Cancer Immunol Res       Date:  2015-05-04       Impact factor: 11.151

3.  TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.

Authors:  Yuanguo Wang; Shaohui Wang; Ciaran P Kelly; Hanping Feng; Andrew Greenberg; Xingmin Sun
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

4.  Expression of Toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea.

Authors:  J Xu; Y Yang; J Sun; Y Ding; L Su; C Shao; B Jiang
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.

Authors:  Takayuki Yamaguchi; Reina Kakefuda; Atsuo Tanimoto; Yoshihiro Watanabe; Nobuyuki Tajima
Journal:  Inflamm Res       Date:  2012-01-14       Impact factor: 4.575

6.  Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages.

Authors:  Sarah G Groft; Nancy Nagy; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

7.  Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathway.

Authors:  Joji Kusuyama; Kenjiro Bandow; Mitsuo Shamoto; Kyoko Kakimoto; Tomokazu Ohnishi; Tetsuya Matsuguchi
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

8.  Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Authors:  Wendy T Watford; Chun-Chi Wang; Christos Tsatsanis; Lisa A Mielke; Aristides G Eliopoulos; Constantine Daskalakis; Nicolas Charles; Sandra Odom; Juan Rivera; John O'Shea; Philip N Tsichlis
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

9.  Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.

Authors:  Lisa A Mielke; Karen L Elkins; Lai Wei; Robyn Starr; Philip N Tsichlis; John J O'Shea; Wendy T Watford
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages.

Authors:  Jianzhong Zhu; Xianzhu Wu; Suchi Goel; Nagaraj M Gowda; Sanjeev Kumar; Gowdahalli Krishnegowda; Gourav Mishra; Rebecca Weinberg; Guangfu Li; Matthias Gaestel; Tatsushi Muta; D Channe Gowda
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.